Obstructive sleep apnea (OSA) is highly associated with the metabolic syndrome or its core components, partly due to the common feature of obesity, but associations independent of obesity have ...

particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS). These two conditions exacerbate each other, creating a vicious cycle that increases the risk ...

The condition can also cause complications including fatigue, high blood pressure, heart problems, and metabolic syndrome, but the causes and risk factors vary. Obstructive sleep apnea (OSA), the ...

Diagnosis AF, atrial flutter, tachycardia–bradycardia syndrome, obstructive sleep apnea and morbid obesity. Management Antiarrhythmic drug therapy, DC cardioversion, anticoagulation, atrial ...

Women with persistent short sleep during the peripartum period had significantly increased odds of developing metabolic syndrome.

a game-changing pharmaceutical option designed to address OSA at its root cause—obesity. The drug works by targeting GLP-1 and GIP receptors, hormones responsible for appetite and metabolic ...

metabolic-dysfunction associated steatotic liver disease (MASLD previously known as nonalcoholic fatty liver disease), obstructive sleep apnea, hypertension, hyperlipidemia, hypothyroidism and ...